n-(3-(aminomethyl)benzyl)acetamidine and tat-nr2b9c

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with tat-nr2b9c in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beamer, E; Beynon, RJ; Hammond, D; Salter, MW; Sills, GJ; Simpson, D; Thippeswamy, T; Tse, K; Tymianski, M1

Other Studies

1 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and tat-nr2b9c

ArticleYear
The impact of postsynaptic density 95 blocking peptide (Tat-NR2B9c) and an iNOS inhibitor (1400W) on proteomic profile of the hippocampus in C57BL/6J mouse model of kainate-induced epileptogenesis.
    Journal of neuroscience research, 2019, Volume: 97, Issue:11

    Topics: Amidines; Animals; Anticonvulsants; Benzylamines; Epilepsy; Hippocampus; Kainic Acid; Male; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Peptides; Proteomics; Status Epilepticus

2019